| Acta Crystallographica Section D Acta Crystallographica Section D BIOLOGICAL CRYSTALLOGRAPHY |
research papers
| BIOLOGICAL CRYSTALLOGRAPHY |
The Protein Data Bank in Europe (PDBe): bringing structure to biology
aProtein Data Bank in Europe (PDBe), EMBL–EBI, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, England
*Correspondence e-mail: gerard@ebi.ac.uk
The Protein Data Bank in Europe (PDBe) is the European partner in the Worldwide PDB and as such handles depositions of X-ray, NMR and EM data and structure models. PDBe also provides advanced bioinformatics services based on data from the PDB and related resources. Some of the challenges facing the PDB and its guardians are discussed, as well as some of the areas on which PDBe activities will focus in the future (advanced services, ligands, integration, validation and experimental data). Finally, some recent developments at PDBe are described.
Keywords: Protein Data Bank in Europe.
1. Introduction
The Protein Data Bank in Europe (PDBe; https://pdbe.org ; Velankar et al., 2010, 2011
), previously known as the European Macromolecular Structure Database (MSD; Velankar et al., 2005
; Tagari et al., 2006
), is the European partner in the Worldwide Protein Data Bank (wwPDB; https://wwpdb.org ; Berman et al., 2007
). Together with its wwPDB partners, RCSB (Kouranov et al., 2006
), PDBj (Standley et al., 2008
) and BMRB (Ulrich et al., 2008
), PDBe accepts depositions of experimentally determined biomacromolecular structures and the underlying experimental data. The deposition sites curate (i.e. annotate, enrich and validate) the structures and the data and make them available in the Protein Data Bank (PDB; Bernstein et al., 1977
; Berman, 2008
). The PDB is the single worldwide archive of biomacromolecular structures. The master copy of the PDB resides on an ftp server hosted by RCSB, with mirrors at PDBe and PDBj. The weekly updates of the PDB are released by all of the wwPDB sites simultaneously at 0:00 UTC (Coordinated Universal Time) on Wednesdays. The archive is freely downloadable and is mirrored by many third-party sites. The wwPDB partners collaborate intensely on all matters related to `data-in'; that is, the deposition and annotation of structures and data and issues related to formats, standards, validation and the description of the ligands that occur in the PDB. However, as regards `data-out' they each offer different and competing services, thus providing alternative ways of delivering and presenting the data in the PDB to the user community through their individual websites.
PDBe was established (initially as MSD) at the European Bioinformatics Institute (EMBL–EBI; https://www.ebi.ac.uk ) in 1995. Under the leadership of Geoff Barton (1998–2001) and Kim Henrick (2001–2009), PDBe built up a reputation as a provider of advanced structural bioinformatics databases and services. PDBe also founded the Data Bank (EMDB; https://emdatabank.org ; Tagari et al., 2002; Henrick et al., 2003
) in 2002. However, like the PDB, EMDB is now an international collaborative effort involving PDBe, RCSB and the laboratory of Wah Chiu at Baylor College of Medicine (BCM) (Lawson et al., 2011
).
In this paper, we discuss some of the challenges facing the PDB and its guardians in the near future. Subsequently, we describe the areas in which PDBe has traditionally been strong or wants to become strong as well as some of our future plans in these areas. Finally, we discuss some recent developments at PDBe.
2. The future of the PDB
There is no doubt that the future of the PDB will involve growth: growth in the number of entries, growth in the size and complexity of entries and growth in the number of experimental techniques (including so-called hybrid methods) that are used to determine the structures of biologically relevant molecules, complexes and machines at anything from very low to atomic resolution. These developments will have profound consequences for PDBe, for wwPDB and for all producers and users of biomacromolecular structures. The wwPDB partners are currently developing a new common deposition and annotation tool that will enable them to handle a greater number of more complex and more diverse structures (and the underlying experimental data) produced by a number of different experimental methods. As structures have become larger and more complex, the limits of the original PDB format (Bernstein et al., 1977) have been reached (and in some cases breached). For this reason, the wwPDB partners, in consultation with community stakeholders, are developing a new more versatile PDB format. Another important area in which the wwPDB partners have joined forces is the validation of structures and data (Kleywegt, 2009
). wwPDB has established validation task forces (VTFs) for X-ray crystallography (Berman et al., 2010
), NMR spectroscopy and cryoelectron microscopy (EM). The recommendations of these task forces will be implemented as part of the deposition and annotation pipeline. The new system will include validation of small molecules bound to macromolecules. These small molecules form an increasingly important component of the structure data available in the archive, but validation of their structures and reliability has been problematic (Kleywegt, 2007
). To remedy this problem, wwPDB has entered into a collaboration with the Cambridge Crystallographic Data Centre (CCDC; https://www.ccdc.cam.ac.uk/ ), giving the wwPDB partners access to CCDC tools and databases. In particular, Mogul (Bruno et al., 2004
), a program for validation of the geometry of small molecules, will become a crucial component of the wwPDB ligand-validation arsenal.
As the PDB approaches its 40th birthday in 2011, everybody involved with it faces an important question: should the PDB should remain a historic archive or not? The PDB has hitherto been an archive of the structural data as described in the primary literature. For instance, the coordinates available in the PDB for a structure determined in 1976 are those described in that year, even though model-building, and validation methodology has advanced enormously since then. Even automatic approaches could produce improved models for the vast majority of crystal structures in the PDB today (Joosten et al., 2009). The PDB is very much a provider-centric archive, which is great for crystallographers and historians but which severely limits the accessibility and usefulness of structural data to non-expert users. Shifts in user communities and user demands, as well as limits on the resources and funding sources available for the maintenance and development of the PDB, put pressure on the structural biology community as a whole to make its findings more accessible, and indeed relevant, to large groups of non-expert users (from medicinal chemists to geneticists and physicians). In our view, during its fifth decade the PDB should be transformed from a historical archive into a useful resource for biomedicine (and related fields such as agriculture). Non-expert users approach the structural archive very differently from structural biologists. They generally think in terms of genes, proteins, pathways, mutations or diseases, not in terms of PDB ID codes. Furthermore, non-experts have great difficulty in telling a good and reliable structure model of a certain molecule from a poor one. These observations have a number of implications for the way in which the structural archive needs to be organized and presented to such users.
|
Some of these requirements have implications for wwPDB as a whole, while others apply to all sites that deliver raw and derived PDB data, including PDBe.
3. PDBe focus areas
PDBe has identified five focus areas in which it either has traditionally been strong or wants to become strong in the near future, namely (i) advanced services, (ii) ligand annotation and analysis, (iii) integration and presentation of biomolecular and other data, (iv) validation and (v) experimental data (presentation, validation and analysis). Some past activities and some ongoing and future developments in each of these areas are described below.
3.1. Advanced services
PDBe has established a reputation as a provider of advanced databases and services built upon the data available in the PDB and other resources, including the following.
3.2. Ligands
The ligand-bound structures in the PDB offer unique insights into the molecular interactions of small molecules and biomacromolecules. In many instances ligands modulate the activity of the protein to which they bind, but sometimes their presence is an artefact of the experimental procedure (e.g. purification or crystallization). Nevertheless, even `accidental' ligands can offer insight into how the natural substrate might interact with its biomacromolecular target. The process of identifying `interesting' ligands will usually require manual annotation. PDBe has started a pilot project on the annotation of such ligand instances based on the simple rule that if a ligand and its environment are discussed in the primary publication of the PDB entry then it is likely to be `interesting'. The ligand is then classified as `biologically interesting' or `experimentally interesting' (e.g. a small molecule bound at a crystallographic special position) and this classification and supporting information are stored in a database for future use.
Presenting protein–ligand interaction data to the wider community presents another challenge, since understanding the three-dimensional nature of the interaction site is not straightforward. Approaches such as LigPlot (Wallace et al., 1996) have been successful in making this information accessible as simplified two-dimensional diagrams with key details about the molecular interactions. The two-dimensional approach, while sophisticated, still has the limitation of not conveying the three-dimensional nature of the binding site. At PDBe we are working to combine customisable and linked two-dimensional and three-dimensional views. Together with annotation of `interesting ligands' this will enhance the value of the PDB archive.
3.3. Integration
PDBe is part of the European Bioinformatics Institute (EBI), which is home to a number of core bioinformatics databases and services that hold data relevant to the biomedical field (Brooksbank et al., 2010). This puts PDBe in a unique position and enables it to enhance the annotation of biological data with insights from the macromolecular structure information available in the PDB and vice versa. This approach to data integration has been a mainstay of the bioinformatics field in the past decade (Chicure, 2002
; Valencia, 2002
). PDBe collaborates primarily with UniProt (UniProt Consortium, 2009
) to integrate information from protein sequences and structures. This collaboration, which started in 2000, has resulted in a data resource called SIFTS (Structure Integration with Function, Taxonomy and Sequences; Velankar et al., 2005
). SIFTS is the authoritative source of up-to-date residue-level annotation of structures in the PDB with data available in UniProt, CATH (Greene et al., 2007
), SCOP (Andreeva et al., 2008
), GOA (Barrell et al., 2009
), InterPro (Hunter et al., 2009
) and Pfam. SIFTS itself is used by major resources such as Pfam, CATH, RCSB, DAS server providers (https://www.dasregistry.org/ ) and many research and service groups around the world. In the future, SIFTS might be extended to link PDB data to other resources such as ChEMBL (https://www.ebi.ac.uk/chembl/ ; protein–ligand interaction data), IntAct (Aranda et al., 2010
; macromolecular interaction data), Reactome (Matthews et al., 2009
; biological pathway data), ChEBI (De Matos et al., 2010
; ligand chemistry and function data) and EnsEMBL (Flicek et al., 2010
; SNPs and genetic variation data).
Although data-integration efforts have resulted in an infrastructure that allows the easy transfer of information and annotations between various bioinformatics resources, this in itself does not necessarily result in additional insight into the biological context, function or role of a given biomacromolecule. Intelligent query and visualization mechanisms using modern tools and technologies are essential for making structure data relevant for the wider biomedical field. Efforts to develop such tools are under way at PDBe and some initial results are described in §4.
3.4. Validation
It is generally difficult for non-expert users of structural data to assess the reliability of the data and inferences based on a macromolecular structure (Kleywegt, 2009). To address this issue, PDBe will create a validation portal for biomacromolecular structure data. As a first step, the Uppsala Electron Density Server (EDS; Kleywegt et al., 2004
) will be integrated into the PDBe infrastructure. The results of the wwPDB validation pipeline will be combined with electron-density data and presented in an integrated validation viewer for X-ray crystal structures. Similar functionality will be developed for structures determined by other experimental methods as the VTFs submit their recommendations to the wwPDB partners.
3.5. Experimental data
NMR contributes about 15% of the structures in the PDB archive. This technique presents several distinct challenges compared with X-ray crystallography, especially with regard to data complexity, consistent data storage and diversity of software. To encourage the community to tackle these issues before deposition, PDBe has been collaborating closely with the Collaborative Computational Project for NMR (CCPN) for the last decade (Fogh et al., 2006; Vranken et al., 2005
). This work has resulted in a deposition system where NMR spectroscopists can upload a complete CCPN project to PDBe from which all information relevant to the PDB is extracted (Penkett et al., 2010
) and NMR data are forwarded to the BioMagResBank (BMRB; Ulrich et al., 2008
). These efforts on consistent data storage have also resulted in software to handle a large variety of NMR data formats (Vranken et al., 2005
) and are used in data-cleanup projects (Doreleijers et al., 2005
, 2009
) and the CASD–NMR software-assessment competition (Rosato et al., 2009
). The large data archives created in this way have made it possible to carry out comprehensive data analyses (Vranken, 2007
; Vranken & Rieping, 2009
) and structure recalculations (Nederveen et al., 2005
; Nabuurs et al., 2004
) and have driven new developments in the field (De Simone et al., 2009
; Rieping & Vranken, 2010
). PDBe continues to work with the NMR community to ensure that there is a public archive with structures that are supported by well defined experimental data. PDBe is also committed to delivering these data back to the community in forms that encourage further developments in the field of biomacromolecular NMR spectroscopy.
Since 2002, PDBe has worked closely with the EM community in establishing and developing the Data Bank (EMDB; Tagari et al., 2002). Initially a purely European affair, the archive is now operated and developed jointly by the three EMDB partner sites PDBe, RCSB and BCM. A deposition and annotation system for EM data was developed at PDBe (Henrick et al., 2003
) and is now available at PDBe and RCSB. The EMDB partner sites are also working on integrating the three-dimensional structure data available in the PDB with EM volume data. The EMDB data can be accessed through the joint website at https://EMDataBank.org (Lawson et al., 2011
).
In addition to the presentation and analysis of NMR and EM data, the integration of EDS into the PDBe service infrastructure will deliver up-to-date electron-density maps and analyses based on the fit of models and data to the user community.
4. New developments at PDBe
PDBe has begun the process of addressing the needs of new communities of users who are not experts in structural biology, a process that is likely to take 5–10 years. In the summer of 2010, PDBe launched its redesigned website (https://pdbe.org ; Velankar et al., 2011; Fig. 1
) which included a number of new features that may be considered first steps on the road to its becoming a useful resource for biomedicine. The home page of PDBe was completely redesigned, with the express aim of making it easier and more intuitive to locate information, resources and services, even for first-time non-expert users. This is achieved by offering menus that describe services and resources by their function rather than by an arcane name, by providing a single search box in the top bar on the home page which will search both PDB and EMDB simultaneously and by providing a number of quick-access tools to retrieve key data based on PDB ID code. The PDBe database can also be queried using database identifiers for various relevant resources such as PubMed, Pfam, SCOP, CATH, EC and InterPro. It is further possible to carry out FASTA (Lipman & Pearson, 1985
) searches against all protein sequences in the PDB from the home page.
| | Figure 1 The new PDBe home page, where the top search bar provides a common interface for simple searches of both PDB and EMDB. The `Quick access' panel allows users to perform the most common tasks such as finding detailed information about a particular PDB entry, searching the PDB by various database identifiers or searching the PDB based on a protein sequence. The menu on the left provides access to many of the PDBe search and browse tools. |
A tool to help new users of the website find the information that they are looking for is the PDBe Wizard (https://pdbe.org/wizard ). The Wizard first tries to establish what the user is looking for and what information they already have. Based on this, it either provides the user with a box in which to enter some input (e.g. a PDB code, author name or UniProt ID) and start a search or it provides a link to a resource or service or a page with more information. At the stage where input is required, there are two helpful buttons. One, labelled `Shortcut', provides hints on how to carry out the same search more quickly using PDBe services directly. The other, labelled `What results will I get?', shows examples of what results can be expected and how they will be presented.
For every PDB entry there is set of `atlas' pages that provide important information about the the sequences of the biomacromolecules, the secondary structure of any proteins, the probable literature references etc. The URLs for these pages are of the form https://pdbe.org/1cbs , where `1cbs' is an example of a PDB ID code of interest. By default, a summary page will be presented that uses plain-English sentences to describe key aspects of the structure and the study, as well as some figures and tables with cross-references to other databases (Fig. 2).
| | Figure 2 Example of an Atlas page, in this case for PDB entry 1lyz . The menu on the left-hand side enables navigation between different areas of information and provides links to other resources and downloadable files. The main panel on the right shows the summary information for the entry. |
PDBe has introduced a new method to convey information about key aspects of a PDB entry using intuitive icons called PDBlogos (https://pdbe.org/pdbprints ; Fig. 3). In order to make the interpretation of the information conveyed by PDBlogos easier and to provide consistent information when a number of PDB entries are compared, PDBe has also developed PDBprints. A PDBprint for a PDB entry is a collection of PDBlogos displayed in a specific order, where each icon represents a well defined category of information. In the first release of PDBprints (summer 2010) the following categories are included:
|
| | Figure 3 PDBlogos and PDBprints. (a) PDBlogos are stylized icons that convey important information about a PDB entry. For example, these two PDBlogos signify that the biomacromolecule in an entry derives from a fungus and that the structure was determined by X-ray crystallography, respectively. (b) By default, PDBlogos are shown on a green background (although this may be set to a different colour on external websites). However, sometimes the background will be grey: this signifies that either the feature symbolized by the PDBlogo is absent or that the underlying data are not available, not published or not deposited. For instance, these two PDBlogos show that an entry does not contain any nucleic acid molecules and that the structure has not (yet) been published, respectively. (c) A PDBprint for a PDB entry is a collection of PDBlogos displayed in a specific order, where each icon represents a well defined category of information (see text). This PDBprint shows immediately that PDB entry 1cbs is a published of a heterologously expressed human protein in complex with a ligand for which the experimental diffraction data have beeen deposited. To help users familiarize themselves with the meaning of PDBlogos, tool tips are presented. |
Fig. 3(c) shows the PDBprint for PDB entry 1cbs , which shows that 1cbs is a published of a heterologously expressed human protein in complex with a ligand for which the experimental diffraction data have been deposited.
In a first attempt to enable users to access the structure archive using familiar biological classifications and to analyse the selected structures in a number of ways, PDBe has introduced a database browser called PDBeXplore. At present, there are three browser modules based on the following classification systems:
|
Fig. 4 shows a glimpse of the enzyme-browser functionality. The browser not only lists all the PDB entries that are relevant for a given query but also provides instant reports and analyses of the relevant structure data. These reports pertain to the distribution of probable quaternary structures, bound ligands, sequence-family data (based on Pfam), taxonomy and fold classifications. All of the information can be downloaded for further off-line use. PDBe offers similar browser functionality for sequence-based searches (https://pdbe.org/fasta ). This tool offers a list of all PDB entries that include proteins that have a sequence similar to the query sequence and provides additional analyses and reports. The browser also shows the alignment of the query and target sequences with annotation about secondary-structure assignment and CATH and Pfam domains (Fig. 5
).
| | Figure 4 The PDBe enzyme-browser tool. The left-hand panel shows the EC classification as a tree and the right-hand panel gives detailed information on the selected class of enzyme. The central panel shows structure data relevant to the selected EC class organized as a number of tabs (e.g. ligands, folds etc.). |
| | Figure 5 The PDBe browser for analysing the results of sequence searches against the PDB. The query sequence can be shown aligned with each of the target sequences, together with their secondary structure, Pfam and CATH domain annotations. |
Acknowledgements
The authors wish to express their gratitude to all present and past members of the PDBe (and MSD) team. They also wish to thank all collaborators and partners in the EBI, EMBL, wwPDB, EMDB and other collaborative efforts, as well as the structural biology community for depositing their experimental data in the PDB and EMDB archives. Funding for PDBe is provided by EMBL–EBI, the Wellcome Trust (grant 088944), NIH (grant R01GM079429-04), BBSRC (grants BB/C512110/1, BB/E007511/1 and BB/G022577/1) and the European Union (grants 226073 and 213010). Some earlier developments were funded by MRC and CCP4.
References
Andreeva, A., Howorth, D., Chandonia, J. M., Brenner, S. E., Hubbard, T. J., Chothia, C. & Murzin, A. G. (2008). Nucleic Acids Res. 36, D419–D425. Web of Science CrossRef PubMed CAS Google Scholar
Aranda, B. et al. (2010). Nucleic Acids Res. 38, D525–D531. Web of Science CrossRef PubMed CAS Google Scholar
Barrell, D., Dimmer, E., Huntley, R., Binns, D., O'Donovan, C. & Apweiler, R. (2009). Nucleic Acids Res. 37, D396–D403. Web of Science CrossRef PubMed CAS Google Scholar
Berman, H. M. (2008). Acta Cryst. A64, 88–95. Web of Science CrossRef IUCr Journals Google Scholar
Berman, H. M., Henrick, K., Nakamura, H. & Markley, J. L. (2007). Nucleic Acids Res. 35, D301–D303. Web of Science CrossRef PubMed CAS Google Scholar
Berman, H. M., Kleywegt, G. J., Nakamura, H., Markley, J. L. & Burley, S. K. (2010). Nature (London), 463, 425. Web of Science CrossRef PubMed Google Scholar
Bernstein, F. C., Koetzle, T. F., Williams, G. J., Meyer, E. F. Jr, Brice, M. D., Rodgers, J. R., Kennard, O., Shimanouchi, T. & Tasumi, M. (1977). J. Mol. Biol. 112, 535–542. CrossRef CAS PubMed Web of Science Google Scholar
Brooksbank, C., Cameron, G. & Thornton, J. M. (2010). Nucleic Acids Res. 38, D17–D25. Web of Science CrossRef PubMed CAS Google Scholar
Bruno, I. J., Cole, J. C., Kessler, M., Luo, J., Motherwell, W. D. S., Purkis, L. H., Smith, B. R., Taylor, R., Cooper, R. I., Harris, S. E. & Orpen, A. G. (2004). J. Chem. Inf. Comput. Sci. 44, 2133–2144. Web of Science CrossRef PubMed CAS Google Scholar
Chicure, M. (2002). Nature (London), 419, 751–757. Google Scholar
De Matos, P., Alcantara, R., Dekker, A., Ennis, M., Hastings, J., Haug, K., Spiteri, I., Turner, S. & Steinbeck, C. (2010). Nucleic Acids Res. 38, D249–D254. Web of Science CrossRef PubMed CAS Google Scholar
De Simone, A., Cavalli, A., Hsu, S.-T. D., Vranken, W. & Vendruscolo, M. (2009). J. Am. Chem. Soc. 131, 16332–16333. Web of Science CrossRef PubMed CAS Google Scholar
Doreleijers, J. F., Nederveen, A. J., Vranken, W., Bonvin, A. M. J. J., Kaptein, R., Lin, J., Markley, J. L. & Ulrich, E. L. (2005). J. Biomol. NMR, 32, 1–12. Web of Science CrossRef PubMed CAS Google Scholar
Doreleijers, J. F., Vranken, W. F., Schulte, C., Lin, J., Wedell, J., Penkett, C. J., Vuister, G. W., Vriend, G., Markley, J. L. & Ulrich, E. L. (2009). J. Biomol. NMR, 45, 389–396. Web of Science CrossRef PubMed CAS Google Scholar
Dowell, R. D., Jokerst, R. M., Day, A., Eddy, S. R. & Stein, L. (2001). BMC Bioinformatics, 2, 7. Google Scholar
Finn, R. D., Mistry, J., Tate, J., Coggill, P., Heger, A., Pollington, J. E., Gavin, O. L., Gunesekaran, P., Ceric, G., Forslund, K., Holm, L., Sonnhammer, E. L., Eddy, S. R. & Bateman, A. (2010). Nucleic Acids Res. 38, D211–D222. Web of Science CrossRef PubMed CAS Google Scholar
Fleischmann, A., Darsow, M., Degtyarenko, K., Fleischmann, W., Boyce, S., Axelsen, K. B., Bairoch, A., Schomburg, D., Tipton, K. F. & Apweiler, R. (2004). Nucleic Acids Res. 32, D434–D437. Web of Science CrossRef PubMed CAS Google Scholar
Flicek, P. et al. (2010). Nucleic Acids Res. 38, D557–D562. Web of Science CrossRef PubMed CAS Google Scholar
Fogh, R. H., Vranken, W. F., Boucher, W., Stevens, T. J. & Laue, E. D. (2006). J. Biomol. NMR, 36, 147–155. Web of Science CrossRef PubMed CAS Google Scholar
Golovin, A., Dimitropoulos, D., Oldfield, T., Rachedi, A. & Henrick, K. (2005). Proteins, 58, 190–199. Web of Science CrossRef PubMed CAS Google Scholar
Golovin, A. & Henrick, K. (2008). BMC Bioinformatics, 9, 312. Google Scholar
Golovin, A. & Henrick, K. (2009). J. Chem. Inf. Model. 49, 22–27. Web of Science CrossRef PubMed CAS Google Scholar
Greene, L. H., Lewis, T. E., Addou, S., Cuff, A., Dallman, T., Dibley, M., Redfern, O., Pearl, F., Nambudiry, R., Reid, A., Sillitoe, I., Yeats, C., Thornton, J. M. & Orengo, C. A. (2007). Nucleic Acids Res. 35, D291–D297. Web of Science CrossRef PubMed CAS Google Scholar
Henrick, K., Newman, R., Tagari, M. & Chagoyen, M. (2003). J. Struct. Biol. 144, 228–237. Web of Science CrossRef PubMed CAS Google Scholar
Henrick, K. & Thornton, J. M. (1998). Trends Biochem. Sci. 23, 358–361. Web of Science CrossRef CAS PubMed Google Scholar
Hunter, S. et al. (2009). Nucleic Acids Res. 37, D211–D215. Web of Science CrossRef PubMed CAS Google Scholar
Joosten, R. P., Womack, T., Vriend, G. & Bricogne, G. (2009). Acta Cryst. D65, 176–185. Web of Science CrossRef CAS IUCr Journals Google Scholar
Kleywegt, G. J. (2007). Acta Cryst. D63, 94–100. Web of Science CrossRef CAS IUCr Journals Google Scholar
Kleywegt, G. J. (2009). Acta Cryst. D65, 134–139. Web of Science CrossRef CAS IUCr Journals Google Scholar
Kleywegt, G. J., Harris, M. R., Zou, J., Taylor, T. C., Wählby, A. & Jones, T. A. (2004). Acta Cryst. D60, 2240–2249. Web of Science CrossRef CAS IUCr Journals Google Scholar
Kouranov, A., Xie, L., de la Cruz, J., Chen, L., Westbrook, J., Bourne, P. E. & Berman, H. M. (2006). Nucleic Acids Res. 34, D302–D305. Web of Science CrossRef PubMed CAS Google Scholar
Krissinel, E. & Henrick, K. (2004a). Acta Cryst. D60, 2256–2268. Web of Science CrossRef CAS IUCr Journals Google Scholar
Krissinel, E. & Henrick, K. (2004b). Softw. Pract. Exp. 34, 591–607. CrossRef Google Scholar
Krissinel, E. & Henrick, K. (2007). J. Mol. Biol. 372, 774–797. Web of Science CrossRef PubMed CAS Google Scholar
Lawson, C. L. et al. (2011). Nucleic Acids Res. 39, D456–D464. Web of Science CrossRef CAS PubMed Google Scholar
Lipman, D. J. & Pearson, W. R. (1985). Science, 227, 1435–1441. CrossRef CAS PubMed Web of Science Google Scholar
Matthews, L. et al. (2009). Nucleic Acids Res. 37, D619–D622. Web of Science CrossRef PubMed CAS Google Scholar
Nabuurs, S. B., Nederveen, A. J., Vranken, W., Doreleijers, J. F., Bonvin, A. M., Vuister, G. W., Vriend, G. & Spronk, C. A. (2004). Proteins, 55, 483–486. Web of Science CrossRef PubMed CAS Google Scholar
Nederveen, A. J., Doreleijers, J. F., Vranken, W., Miller, Z., Spronk, C. A. E. M., Nabuurs, S. B., Güntert, P., Livny, M., Markley, J. L., Nilges, M., Ulrich, E. L., Kaptein, R. & Bonvin, A. M. J. J. (2005). Proteins, 59, 662–672. Web of Science CrossRef PubMed CAS Google Scholar
Penkett, C. J., van Ginkel, G., Velankar, S., Swaminathan, J., Ulrich, E. L., Mading, S., Stevens, T. J., Fogh, R. H., Gutmanas, A., Kleywegt, G. J., Henrick, K. & Vranken, W. F. (2010). J. Biomol. NMR, 48, 85–92. Web of Science CrossRef CAS PubMed Google Scholar
Rieping, W. & Vranken, W. F. (2010). Proteins, 78, 2482–2489. Web of Science CAS PubMed Google Scholar
Rosato, A. et al. (2009). Nature Methods, 6, 625–626. Web of Science CrossRef PubMed CAS Google Scholar
Standley, D. M., Kinjo, A. R., Kinoshita, K. & Nakamura, H. (2008). Brief. Bioinform. 9, 276–285. Web of Science CrossRef PubMed CAS Google Scholar
Tagari, M., Newman, R., Chagoyen, M., Carazo, J. M. & Henrick, K. (2002). Trends Biochem. Sci. 27, 589. Web of Science CrossRef PubMed Google Scholar
Tagari, M., Tate, J., Swaminathan, G. J., Newman, R., Naim, A., Vranken, W. F., Kapopoulou, A., Hussain, A., Fillon, J. & Henrick, K. (2006). Nucleic Acids Res. 34, D287–D290. Web of Science CrossRef PubMed CAS Google Scholar
Ulrich, E. L. et al. (2008). Nucleic Acids Res. 36, D402–D408. Web of Science CrossRef PubMed CAS Google Scholar
UniProt Consortium (2009). Nucleic Acids Res. 37, D169–D174. CrossRef PubMed Google Scholar
Valencia, A. (2002). Bioinformatics, 18, 1551–1552. Web of Science CrossRef PubMed CAS Google Scholar
Velankar, S. et al. (2010). Nucleic Acids Res. 38, D308–D317. Web of Science CrossRef PubMed CAS Google Scholar
Velankar, S. et al. (2011). Nucleic Acids Res. 39, D402–D410. Web of Science CrossRef CAS PubMed Google Scholar
Velankar, S., McNeil, P., Mittard-Runte, V., Suarez, A., Barrell, D., Apweiler, R. & Henrick, K. (2005). Nucleic Acids Res. 33, D262–D265. Web of Science CrossRef PubMed CAS Google Scholar
Vranken, W. F. (2007). J. Biomol. NMR, 39, 303–314. Web of Science CrossRef PubMed CAS Google Scholar
Vranken, W. F., Boucher, W., Stevens, T. J., Fogh, R. H., Pajon, A., Llinas, M., Ulrich, E. L., Markley, J. L., Ionides, J. & Laue, E. D. (2005). Proteins, 59, 687–696. Web of Science CrossRef PubMed CAS Google Scholar
Vranken, W. F. & Rieping, W. (2009). BMC Struct. Biol. 9, 20. Google Scholar
Wallace, A. C., Laskowski, R. A. & Thornton, J. M. (1996). Protein Eng. 8, 127–134. CrossRef Web of Science Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
| BIOLOGICAL CRYSTALLOGRAPHY |